REFERENCES
- Abdou H. M. Dissolution. Remington's Pharmaceutical Sciences. 18th Ed., Mack Publishing Company. 1990
- Quality of Prolonged Release Oral Solid Dosage Forms. International Conference on Harmonization. 1991, 89–93, Guidelines Eudra/Q/91/025
- Gibaldi M., Feldman S. Establishment of Sink Conditions in Dissolution Rate Determinations—Theoretical Considerations and Application to Nondisintegrating Dosage Forms. J. Pharm. Sci. 1967; 56: 1238–1242
- Khan K. A., Rhodes C. T. Effect of Compaction Pressure on the Dissolution Efficiency of Some Direct Compression Systems. Pharm. Act. Helv. 1972; 47: 594–607
- Khan K. A. The Concept of Dissolution Efficiency. J. Pharm. Pharm. 1975; 27: 48–49
- Higuchi T. Rate of Release of Medicaments from Ointment Bases Containing Drugs in Suspension. J. Pharm. Sci. 1961; 50: 874–875
- Higuchi T. Mechanism of Sustained-Action Medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices. J. Pharm. Sci. 1963; 52: 1145–1149
- Cobby J., Mayersohn M., Walker G. C. Influence of Shape Factors on Kinetics of Drug Release from Matrix Tablets. II: Experimental. J. Pharm Sci. 1974; 63: 732–737
- Gibaldi M., Feldman S. Establishment of Sink Conditions in Dissolution Rate Determinations—Theoretical Considerations and Application to Nondisintegrating Dosage Forms. J. Pharm Sci. 1967; 56: 1238–1242
- Wagner J. G. Interpretation of Percent Dissolved-Time Plots Derived from In Vitro Testing of Conventional Tablets and Capsules. J. Pharm Sci. 1969; 58: 1253–1257
- Baker R. W., Lonsdale H. S. Controlled Release: Mechanisms and Rates. Controlled Release of Biologically Active Agents, A. C. Taquary, R. E. Lacey. Plenum Press, New York 1974; 15–71
- Hixson A. W., Crowell J. H. Dependence of Reaction Velocity upon Surface and Agitation. Ind. Eng. Chem. 1931; 23: 923–931
- Langenbucher F. Linearization of Dissolution Rate Curves by the Weibull Distribution. J. Pharm. Pharm. 1972; 24: 979–981
- Goldsmith J. A., Randall N., Ross S. D. On Methods of Expressing Dissolution Rate Data. J. Pharm. Pharm. 1978; 30: 347–349
- Romero P., Costa J. B., Castel-Maroteaux, Chulia D. Statistical Optimization of a Controlled Release Formulation Obtained by a Double Compression Process: Application of a Hadamard Matrix and a Factorial Design. Pharmaceutical Technology, Controlled Drug Release, J. I. Wells, M. H. Rubinstein. Ellis Horwood, New York 1991; 2: 44–58
- Vudathala G. K., Rogers J. A. Dissolution of Fludrocortisone from Phospholipid Coprecipitates. J. Pharm. Sci. 1992; 82: 282–286
- Korsmeyer R. W., Gurny R., Doelker E. M., Buri P., Peppas N. A. Mechanism of Solute Release from Porous Hydrophilic Polymers. Int. J. Pharm. 1983; 15: 25–35
- Peppas N. A. Analysis of Fickian and Non-Fickian Drug Release from Polymers. Pharm. Acta Helv. 1985; 60: 110–111
- Harland R. S., Gazzaniga A., Sangalli M. E., Colombo P., Peppas N. A. Drug/Polymer Matrix Swelling and Dissolution. Pharm. Res. 1988; 5: 488–494
- Moore J. W., Flanner H. H. Mathematical Comparison of Dissolution Profiles. Pharm. Tech. 1996; 20: 64–74
- Center for Drug Evaluation and Research. Guidance for Industry Immediate Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation. CMC 6, Center for Drug Evaluation and Research. November 1995
- Remington's Pharmaceutical Sciences. 18th Ed., Mack Publishing Company. 1990; 854–855
- Uniformity of Mass of Single-Dose Preparations. European Pharmacopoeia. 3rd Ed., Council of Europe, France 1997; 133
- Mendes R. W. Tablet Binders. Drug Cosmet. Chem. 1968; 103: 46–49
- U.S. Pharmacopeial Convention. Diltiazem Hydrochloride Extended-Release Capsules. United States Pharmacopoeia 23/National Formulary 18. U.S. Pharmacopeial Convention, Rockville, MD 1995; 525–526
- U.S. Pharmacopeial Convention. Diltiazem Hydrochloride Tablets. United States Pharmacopoeia 23/National Formulary 18. U.S. Pharmacopeial Convention, Rockville, MD 1995; 525
- Liu J. P., Chow S. C. Statistical Issues on the FDA Conjugated Estrogen Tablets Bioequivalence Guidance. Drug Inf. J. 1996; 30: 881–889
- Liu J. P., Ma M. C., Chow S. C. Statistical Evaluation of Similarity Factor f2 as a Criterion for Assessment of Similarity Between Dissolution Profiles. Drug Inf. J. 1997; 31: 1255–1271
- Shah V. P., Gurbarg M., Noory A., Dighe S., Skelly J. P. Influence of Higher Rates of Agitation on Release Patterns of Immediate-Release Drug Products. J. Pharm. Sci. 1992; 81: 500–503